The company that was established in 2019 has a highly qualified management team whose expertise ranges from product development in medical sector to investment and marketing.
Having developed a technology of using nanotechnology as a vector for initiating antigen antibody reactions it initially intended to use this technology in the diagnosis of COVID19 antigens and antibodies in a single cassette.
The company is exploring a completely new device design, this design of the cassette involves using microfluidics and can be graphically explained during a meeting. It would like to discuss the feasibility of the proposed design of the device.
The company is seeking to work with suitable partners under licensing, manufacturing or commercial agreement with technical assistance agreements.
Advantages & innovations
UNITED KINGDOM
Stage of development
Under development/lab tested
Partner sought
The partner should have experience in manufacturing prototypes for validation studies in the diagnostic medical product field and should have experience in scaling production from 200000 units to 5M units over a 12 month period.
The company is looking to work with partners under licensing, manufacturing or commercial agreements with technical assistance agreements.